Cannabis investors have spent the better part of five years learning a hard lesson: top-line growth doesn't count for much if a company can't turn revenue into cash. Dozens of multi-state operators overexpanded, layered on debt, or diluted shareholders repeatedly just to keep the lights on. Green Thumb Industries (OTC: GTBIF) took a different path, and its first-quarter results show why the company is regarded as one of the sector's steadier operators.
Revenue rose 7.4% year over year to $300.2 million. More importantly, the company generated $76 million in operating cash flow and $93.5 million in normalized EBITDA, while posting GAAP net income of $15.4 million. In a business where margin compression and inventory shrinkage routinely eat into projected profits, that kind of consistency is rare. Retail execution matters here - the same discipline that shows up in POS terminals, compliance logs, and wholesale menus at the store level tends to show up in the balance sheet, and operators evaluating back-end systems, including platforms like cannabis pos montana, are essentially making a bet on that same operational rigor scaling across markets.
Balance sheet strength backs up the operating numbers. Green Thumb ended the quarter with roughly $344.5 million in cash and equivalents against $289.9 million in total debt - a comfortable position in an industry where many operators are still working through restructured debt loads. Rather than issuing new shares to raise capital, a move that dilutes existing holders and often signals cash strain, management has been buying stock back. The company repurchased about 6 million shares for $33.3 million during the quarter, then added another 7.4 million shares after quarter-end, pushing total 2025 repurchases to nearly $78 million. That's not a rounding error.
What the Buybacks Signal to the Market
Buybacks of that size tell you two things. First, management believes the stock is undervalued relative to the cash the business throws off. Second, and this is the more important point for anyone underwriting cannabis equities, the company evidently has enough free cash flow to reward shareholders without starving the growth pipeline. That's a luxury very few plant-touching operators can claim right now, given how 280E tax treatment continues to compress net margins across the industry regardless of state-level performance.
Selective Expansion Over Growth at Any Cost
Green Thumb now runs more than 110 Rise dispensaries nationally, with exposure to both medical and adult-use markets - a hedge that matters as some mature states see wholesale pricing soften. New footprint additions in Minnesota and Texas reflect a selective approach rather than a land grab. That distinction matters. License caps, social equity provisions, and local zoning rules vary widely state to state, and operators who chase every open market often end up carrying underperforming stores and compliance overhead they can't support. Green Thumb's calculus appears to be the opposite: enter where the unit economics work, not where the headlines are loudest.
The Federal Question Still Looms
None of this erases the structural challenges facing the industry. Federal legalization remains unresolved, 280E continues to impose an outsized tax burden on companies that would otherwise be ordinary profitable retailers, and pricing pressure persists in saturated adult-use markets. Smaller, higher-risk operators may offer more upside if federal reform accelerates. But Green Thumb's bet is different - it's built a profitable, cash-generating business under today's rules rather than waiting on tomorrow's legislation, which in an industry defined by unmet promises is itself a notable achievement.
